Definitive Contract 75N93022C00053
Award Date 9/1/22
Potential Completion Date 10/31/26
Potential Value $6.8M
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Durham, NC 27710, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
10
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, has awarded a $21,659,151.36 definitive cost-no-fee contract to Duke University to support the "ADVANCED DEVELOPMENT OF A NEUTRALIZING ANTIBODY VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES." This contract, which does not have a set-aside designation, will run through September 18, 2026. Duke University's Office of Research Administration Division will serve as the prime contractor on this...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $19,829,599.29 definitive cost-no-fee contract to Duke University for a Nonhuman Primate Core Humoral Immunology Laboratory to support AIDS vaccine research and development. The contract has a period of performance through March 29, 2025 and does not have a set-aside designation. Duke University's Office of Research Administration Division is the prime contractor for this award, which appears to be...
- This federal contract award to Duke University was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian agency. The $13,368,236.91 definitive contract is for an "IMMUNOLOGY QUALITY ASSESSMENT PROGRAM" and does not have a set-aside designation. Duke University's Office of Research Administration Division is the prime contractor, and the contract has a period of performance ending on September...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Duke University for the production of a protein called A. CON-ENV-03 140CF. The contract has a firm fixed price of $149,839.00 and was awarded on May 10, 2012, with a completion date of June 8, 2012. The contract was not set aside for any specific socioeconomic designation. Duke University, through its Office of Research...
- This federal contract award, valued at $13,243,407.79, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Duke University's Office of Research Administration Division. The contract, titled "TAS::75 0885::TAS MODELING IMMUNITY FOR BIODEFENSE," is a Definitive Contract with a Cost No Fee pricing type. It has an ultimate completion date of September 29, 2015 and was initially awarded on September 30, 2010....
- This is a $2,361,452.65 federal contract award to Duke University, a private non-profit university, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is for a Phase 1 Clinical Trial Unit to develop therapeutics against infectious diseases. It is a delivery order placed under the Therapeutics Against Infectious Diseases Phase 1 indefinite delivery, indefinite quantity (IDIQ) contract. The contract has no...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Duke University, a private non-profit research institution, for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases. The $106,491.59 delivery order contract has an ultimate completion date of December 14, 2020 and does not have a set-aside designation. This award is part of a larger master Indefinite Delivery Vehicle (IDV) contract focused on...
- Duke University has been awarded a cost-no-fee task order valued at $10.38 million by the National Institutes of Health National Institute of Allergy and Infectious Diseases. The task order was issued against Duke University's existing preclinical and translational vaccine development IDIQ with the agency. Under this task order, Duke University will provide services and materials to support in vitro transcription reactions, mRNA purification, and procurement of lipid raw materials for...
- This is a delivery order awarded to Duke University under the Vaccine and Treatment Evaluation Units (VTEU) program, which is managed by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency. The $7,573,172.56 award is for consultation and testing of cytokine levels and cell activation in clinical samples. Duke University, a private research university, is the prime contractor for this cost-no-fee contract with a performance period ending on December 31, 2023....
- This is a federal contract award to Duke University, a private university, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which supports clinical research on vaccines and treatments for infectious diseases. The specific award is for Task B1C1 under contract HHSN272201300017I, with a ceiling value of $1,154,053.22. The award date was...